A Phase I trial of GMA102 for treatment of type 2 diabetes.
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Glutazumab (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 12 Jan 2017 New trial record
- 28 Apr 2016 According to a Gmax Biopharm media release, company has received permission to conduct this trial in Australia.